We are live on ! Find out more
CCA

Cravens & Co Advisors Portfolio holdings

AUM $154M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+17.67%
3 Year Est. Return
+52.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$14.3M
Cap. Flow
+$11.2M
Cap. Flow %
8.35%
Top 10 Hldgs %
65.19%
Holding
80
New
8
Increased
28
Reduced
24
Closed
10

Top Buys

Rank Stock Value
1
TFLO icon
iShares Treasury Floating Rate Bond ETF
TFLO
+$3.87M
2
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$2.81M
3
DBND icon
DoubleLine Opportunistic Bond ETF
DBND
+$1.45M
4
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$1.31M
5
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$1.28M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$1.33M
2
ASML icon
ASML
ASML
+$1.18M
3
NFLX icon
Netflix
NFLX
+$673K
4
AVGO icon
Broadcom
AVGO
+$541K
5
PFE icon
Pfizer
PFE
+$531K

Sector Composition

Rank Sector Weight
1 Financials 15.32%
2 Technology 6.54%
3 Healthcare 4.92%
4 Consumer Discretionary 4.09%
5 Communication Services 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MO icon
51
Altria Group
MO
$122B
$380K 0.28%
8,347
+384
+5% +$17K
NVS icon
52
Novartis
NVS
$295B
$373K 0.28%
3,507
– –
MSOS icon
53
AdvisorShares Pure US Cannabis ETF
MSOS
$864M
$362K 0.27%
49,453
– –
XYZ
54
Block Inc
XYZ
$45.9B
$355K 0.26%
5,511
+362
+7% +$25.3K
CNQ icon
55
Canadian Natural Resources
CNQ
$96.9B
$355K 0.26%
9,968
-730
-7% -$27.5K
LHX icon
56
L3Harris
LHX
$55.9B
$341K 0.25%
1,519
– –
GSK icon
57
GSK
GSK
$103B
$321K 0.24%
8,340
-197
-2% -$8.29K
DUK icon
58
Duke Energy
DUK
$102B
$296K 0.22%
2,958
-227
-7% -$22.7K
RF icon
59
Regions Financial
RF
$26.3B
$288K 0.21%
14,389
– –
TRP icon
60
TC Energy
TRP
$73.5B
$273K 0.2%
+7,190
New +$273K
VALE icon
61
Vale
VALE
$62.9B
$253K 0.19%
22,616
-1,034
-4% -$12.4K
CCI icon
62
Crown Castle
CCI
$32.7B
$250K 0.19%
+2,558
New +$252K
WFC icon
63
Wells Fargo
WFC
$261B
$245K 0.18%
4,125
– –
BMY icon
64
Bristol-Myers Squibb
BMY
$127B
$243K 0.18%
+5,843
New +$261K
VOE icon
65
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$235K 0.17%
1,560
– –
KO icon
66
Coca-Cola
KO
$354B
$230K 0.17%
3,620
– –
FFBC icon
67
First Financial Bancorp
FFBC
$3.55B
$215K 0.16%
9,669
– –
CGGO icon
68
Capital Group Global Growth Equity ETF
CGGO
$11.2B
$205K 0.15%
6,947
-201
-3% -$5.81K
F icon
69
Ford
F
$57.3B
$180K 0.13%
14,358
-5,147
-26% -$63.7K
VTNR
70
DELISTED
Vertex Energy, Inc
VTNR
$12.1K 0.01%
+12,800
New +$15K
ASML icon
71
ASML
ASML
$675B
– –
-1,212
Closed -$1.18M
DIS icon
72
Walt Disney
DIS
$165B
– –
-1,795
Closed -$220K
EPAM icon
73
EPAM Systems
EPAM
$4.69B
– –
-732
Closed -$202K
FIS icon
74
Fidelity National Information Services
FIS
$21.5B
– –
-4,476
Closed -$332K
MU icon
75
Micron Technology
MU
$1.04T
– –
-11,275
Closed -$1.33M
1 2
3
4

Similar funds

CPCP
Cedar Point Capital Partners Cedar Rapids, Iowa $154M AUM 16.57% 1-Year Est. Return
SOWAS
Silver Oak Wealth Advisors Services Los Angeles, California $154M AUM 13.96% 1-Year Est. Return
AFC
Alpine Fox Capital Las Vegas, Nevada $154M AUM
SHU
SBI Holdings USA Santa Clara, California $154M AUM
FW
Fidato Wealth Middleburg Heights, Ohio $154M AUM 11.98% 1-Year Est. Return
FGI
Foresight Global Investors Purchase, New York $154M AUM 26.15% 1-Year Est. Return
HPM
H. Partners Management New York $154M AUM 19.94% 1-Year Est. Return
MDP
Millbank Dartmoor Portsmouth Asheville, North Carolina $154M AUM

Cravens & Co Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Cravens & Co Advisors held 80 positions worth $135M, up 12% from $120M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Cravens & Co Advisors deployed $11.2M of net new capital in Q2 2024, opening 8 new positions and adding to 28 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 2,276 shares worth $1.07M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Netflix, an estimated $673K trimmed.

  • Cravens & Co Advisors's largest Q2 2024 buy was Vertex Pharmaceuticals: 2,276 shares worth $1.07M.
  • Cravens & Co Advisors added most to iShares Treasury Floating Rate Bond ETF in Q2 2024, an estimated $3.87M increase.
  • Cravens & Co Advisors's biggest Q2 2024 reduction was Netflix, cutting an estimated $673K.
  • Cravens & Co Advisors fully exited Micron Technology in Q2 2024, selling an estimated $1.33M.
  • Cravens & Co Advisors's ten largest holdings make up 65% of its $135M portfolio in Q2 2024.
  • Cravens & Co Advisors opened 8 new positions and closed 10 in Q2 2024.
  • Cravens & Co Advisors's portfolio value rose 12% quarter-over-quarter to $135M.

Based on Cravens & Co Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.